Tesla
TSLA
MicroStrategy
MSTR
MARA Holdings
MARA
Apple
AAPL
Microsoft
MSFT
US Stock MarketDetailed Quotes
HOOK HOOKIPA Pharma
- 2.130
- -0.010-0.47%
Close Dec 13 16:00 ET
- 2.130
- 0.0000.00%
Post 20:01 ET
21.08MMarket Cap-0.58P/E (TTM)
2.150High1.880Low80.05KVolume2.120Open2.140Pre Close161.07KTurnover1.67%Turnover RatioLossP/E (Static)9.89MShares11.30052wk High0.29P/B10.21MFloat Cap1.88052wk Low--Dividend TTM4.79MShs Float200.000Historical High--Div YieldTTM12.62%Amplitude1.880Historical Low2.012Avg Price1Lot Size
About HOOKIPA Pharma Company
HOOKIPA Pharma, Inc. is a clinical stage biopharmaceutical company, which engages in developing pharmaceutical products to prevent and cure infectious diseases and cancer. The firm also focuses on immunotherapeutics based on its proprietary arenavirus platform that is designed to reprogram the body's immune system. The company was founded by Rolf M. Zinkernagel, Andreas Bergthaler, Lukas Flatz, and Daniel D. Pinschewer in 2011 and is headquartered in New York, NY.
Company Profile
SymbolHOOK
Company NameHOOKIPA Pharma
Listing DateApr 18, 2019
Issue Price14.00
Founded2011
CEODr. Malte Peters, M.D.
MarketNASDAQ
Employees179
Fiscal Year Ends12-31
Address350 Fifth Avenue,72nd floor, Suite 7240
CityNew York
ProvinceNew York
CountryUnited States of America
Zip Code10118
Phone43-1-890-6360
Websitehttp://www.hookipapharma.com
Company Executives
- Name
- Position
- Salary
- Dr. Malte Peters, M.D.
- Director, Chief Executive Officer and President
- 232.31K
- Mark Winderlich
- Chief Development Officer
- --
- Terry Coelho
- Director, Executive Vice President, Principal Accounting Officer and Chief Financial Officer
- 85.88K
- Roman Necina
- Chief Operations Officer
- --
- Klaus Orlinger
- Chief Scientific Officer
- --
- Julie O'Neill
- Non-Executive Chairman of the Board
- 67.74K
- Dr. David Ross Kaufman, M.D.,PhD
- Independent Director
- 71.74K
- Sean A. Cassidy
- Independent Director
- --
Trending US Stocks
Fed Rate Cut Beneficiaries Fed Rate Cut Beneficiaries
Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data. Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data.